KRAS and neoplasm: A study found that exosomes loaded with clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 could target the KRAS G12D-mutant allele in PDAC cells to suppress cell proliferation and tumor growth, making it a promising treatment strategy [90].